PYXS stock pitch - 2022-07-22

Added to YB: 2022-07-22

Pitch date: 2022-07-22

Pyxis Oncology, Inc.

current return

Author Info

No bio for this author

Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium

Company Info

Pyxis Oncology, Inc., a clinical stage company, engages in the development of therapeutics to treat solid tumors.

Market Cap

$260.2M

Pitch Price

$2.83

Price Target

N/A

Dividend

N/A

EV/EBITDA

-3.01

P/E

-2.22

EV/Sales

22.20

Sector

Biotechnology

A summary for this pitch has not been created yet.